Jefferies London Healthcare Conference 2022

Lys Therapeutics is participating this week to the #Jefferies Healthcare Conference in London, (November 15-17), with Manuel BLANC, CEO, Philippe Dujardin, CFO, and Laurent CONTAUT, Chief Development Officer.

Looking forward to meeting you there!

#JefferiesHealthcare #BD #partnering #healthcare #LysTherapeutics #glunomab #glunozumab